ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Press Information

ASN Press Releases: 2025

$3 MILLION DONATION FROM THE VERTEX FOUNDATION ESTABLISHES A NEW AMERICAN SOCIETY OF NEPHROLOGY INITIATIVE: EXCELLENCE IN KIDNEY CARE IMMUNOLOGY, TRAINING, AND EDUCATION

Latest Release: $3 MILLION DONATION FROM THE VERTEX FOUNDATION ESTABLISHES A NEW AMERICAN SOCIETY OF NEPHROLOGY INITIATIVE: EXCELLENCE IN KIDNEY CARE IMMUNOLOGY, TRAINING, AND EDUCATION

Wednesday, November 12, 2025
• The Vertex Foundation has committed to contributing $3 million to the American Society of Nephrology (ASN) to establish Excellence in Kidney Care Immunology, Training, and Education (EKCITE). • This program will train the kidney workforce in the implementation of the new immune-mediated therapies across a spectrum of kidney diseases.

View Press Release

Subscribe to ASN Press Releases

Stay on top of the latest happenings with the Society and in the nephrology world by subscribing to the ASN Press Release RSS Feed.


More Press Releases

  • Study Reveals a Potentially Better Way to Optimize the Timing for Kidney Transplant Waitlisting
    • Expanding the waitlisting criteria for kidney transplantation to include risk of kidney failure—rather than taking a single measurement of kidney function—could improve outcomes in younger patients and reduce racial disparities in access to kidney transplantation. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • Study Reports on Global Trends in Acute Kidney Injury–Related Mortality
    • A global analysis indicates that countries with higher socioeconomic status and older populations are experiencing increasing rates of acute kidney injury–related mortality, a trend projected to continue through 2050. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • Transitional Dialysis Program in Texas Decreased the Use of Emergency Dialysis
    • A transitional dialysis program piloted in Austin, TX lowered the use of costly emergency dialysis in uninsured people with kidney failure, and it facilitated permanent dialysis access placement and transplant evaluations. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • Quality Improvement Intervention May Help Prevent Deaths from Metformin-Associated Lactic Acid
    • A diagnosis and treatment protocol including the prompt initiation of dialysis led to reduced mortality from metformin-associated lactic acidosis at a hospital in Thailand. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • Conservative Care Versus Dialysis: Model Indicates Which Is Best for Individual Patients with Advanced Chronic Kidney Disease
    • Researchers developed and validated a model that estimates individualized survival probabilities with conservative management versus dialysis in patients with advanced chronic kidney disease. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health
    The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at the American Society of Nephrology Kidney Week 2025 November 5–9.
    Saturday, November 8, 2025
  • Sotagliflozin Outperforms Dapagliflozin for Reducing Salt-Sensitive Hypertension and Kidney Injury in Rats
    • Dual inhibition of sodium-glucose co-transporters 1 and 2 with the recently approved drug sotagliflozin may be an especially effective treatment for salt-sensitive hypertension. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Friday, November 7, 2025
  • Trial Analysis Reveals Almost All Adults with Hypertensive Chronic Kidney Disease Would Benefit from Intensive Blood Pressure Lowering
    • Nearly all SPRINT participants with hypertension and nondiabetic chronic kidney disease stages 3–4 had a net benefit (the predicted difference between benefits and harms) that favored a systolic blood pressure target of <120 mm Hg compared with <140 mm Hg. • The findings will be presented at American Society of Nephrology (ASN Kidney Week 2025 November 5–9.
    Friday, November 7, 2025
  • Study Uncovers Glomerular Disease Outcomes Across the Lifespan
    • A recent analysis of 2,915 patients with primary glomerular diseases indicates that young patients may face similar risks of kidney function decline as older patients, indicating that they are more likely to need dialysis or a kidney transplant during their lifetimes. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.
    Friday, November 7, 2025
  • High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health
    Houston, TX (November 7, 2025) — The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2025 November 5–9.
    Friday, November 7, 2025
  • High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health
    Houston, TX (November 6, 2025) — The results of high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2025 November 5–9.
    Thursday, November 6, 2025
  • $2 MILLION DONATION FROM SATELLITE HEALTHCARE ESTABLISHES NORMAN AND SANDRA COPLON RESEARCH SCHOLAR GRANT
    • Satellite Healthcare, Inc., has committed to contributing $2 million to KidneyCure, which the American Society of Nephrology (ASN) will match, to endow a Transition to Independence Grant. • Named for the founder of Satellite Healthcare and his wife, the Norman and Sandra Coplon Research Scholar Grant will be awarded annually beginning in 2026.
    Friday, October 24, 2025
  • KIDNEYCURE INCREASES COMMITMENT TO STRENGTHEN KIDNEY RESEARCH
    • KidneyCure, the philanthropic foundation of the American Society of Nephrology (ASN), is committing up to $6 million over the next three years for bridge grants to strengthen the kidney research workforce. • Narrowing NIH paylines are resulting in fewer independent kidney researchers endangering the research workforce pipeline and future treatments for kidney diseases. • Bridge grants will help independent researchers keep their labs open, continue their research, and earn future NIH support.
    Tuesday, October 14, 2025
  • AMERICAN SOCIETY OF NEPHROLOGY RELEASES NEW KIDNEY HEALTH GUIDANCE ON IMPACT AND MANAGEMENT OF POTASSIUM AND PHOSPHORUS ADDITIVES FOR PEOPLE WITH KIDNEY DISEASE
    The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG) addressing how potassium and phosphorus additives impact health risks (hyperkalemia and CKD-mineral and bone disorder) for people with kidney disease. The guidance, now available in the Journal of the American Society of Nephrology (JASN), was developed by the ASN KHG Workgroup on Food Additives to provide kidney care professionals with practical strategies to help patients understand and manage the consumption of potassium and phosphorus additives
    Thursday, September 18, 2025
  • KIDNEYCURE ANNOUNCES 2025 GRANT RECIPIENTS
    KidneyCure today announced the addition of 23 new grant recipients for 2025, each of whom will receive much needed funding to continue their work in groundbreaking kidney research. The 2025 grant recipients, listed below, join an accomplished cohort of KidneyCure grantees who are making discoveries that will improve the lives of people with kidney diseases.
    Tuesday, July 1, 2025
  • CHARUHAS V. THAKAR, MD, FASN NAMED EDITOR-IN-CHIEF OF KIDNEY360
    The American Society of Nephrology (ASN) today announced that Professor Charuhas V. Thakar, MD, FASN has been appointed as Editor-in-Chief of Kidney360, ASN's monthly open-access, online only journal. Dr. Thakar currently serves as Director of the Wellcome-Wolfson Institute of Experimental Medicine at Queens University, Belfast, Northern Ireland and will be the second Editor-in-Chief of Kidney360. His six-year term will begin on January 1, 2026. Prior to this role, he served as the Robert G. Luke Endowed Chair and Division Director of Nephrology at University of Cincinnati and Chief of Renal Section at the Cincinnati VA Medical Center.
    Friday, June 13, 2025
  • AMERICAN SOCIETY OF NEPHROLOGY IS PLEASED TO ANNOUNCE THE DEVELOPMENT OF THE CENTERS OF EXCELLENCE IN HOME DIALYSIS PROGRAM
    The American Society of Nephrology (ASN) is designing a pilot Centers of Excellence in Home Dialysis program intended to recognize health care organizations that meet or exceed national standards and evidence-based guidelines in the care and treatment of people on home dialysis. The program's goal is to enhance patient outcomes while increasing access to home modalities and strengthening the infrastructure of home dialysis programs in North America
    Monday, April 28, 2025
  • AMERICAN SOCIETY OF NEPHROLOGY CALLS ON CONGRESS TO AUTHORIZE LEGISLATION AND INCREASE FUNDING FOR KIDNEY DISEASES
    • Today, leaders of the American Society of Nephrology (ASN) are meeting with Congress to continue the process of modernizing the US transplant system, improving efficiency, transparency, and technology to better support the more than 100,000 Americans waiting for an organ transplant. • ASN is advocating for a $67 million appropriation for the Health Resources and Services Administration (HRSA) Organ Transplant Program in Fiscal Year 2026. • ASN champions the Honor Our Living Donors Act, a bill to simplify the process by which living donors can have the costs associated with donating a kidney offset. • ASN is also calling for $25 million in funding for KidneyX to continue to catalyze the development of better preventive, diagnostic, and therapeutic tools to manage kidney diseases
    Wednesday, March 19, 2025
  • AMERICAN SOCIETY OF NEPHROLOGY COMMENDS SENATORS BOOZMAN AND LUJÁN FOR CHAMPIONING THE HONOR OUR LIVING DONORS (HOLD) ACT
    Washington, DC (March 12, 2025) – The American Society of Nephrology (ASN) commends Senators John Boozman (R-AR) and Ben Ray Luján (D-NM) for introducing legislation to better support living donors, the Honor Our Living Donors (HOLD) Act.
    Wednesday, March 12, 2025
  • AMERICAN SOCIETY OF NEPHROLOGY RELEASES KIDNEY HEALTH GUIDANCE ON THE OUTPATIENT MANAGEMENT OF PATIENTS WITH DIALYSIS-REQUIRING ACUTE KIDNEY INJURY
    The American Society of Nephrology (ASN) today released the ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury in the Journal of the American Society of Nephrology (JASN).
    Thursday, February 27, 2025
  • Joint Statement from ASN, ERA, and ISN: Announcing the ASN-ERA-ISN Kidney Support Initiative
    The leadership of the American Society of Nephrology (ASN), the European Renal Association (ERA), and the International Society of Nephrology (ISN) launched the ASN-ERA-ISN Kidney Support Initiative in December 2023.
    Tuesday, February 18, 2025